More Business Wire

View Older Stories View Newer Stories

Feb 24, 2025 07:30AM Bowman to Provide Aerial Orthoimagery Services for North Carolina CGIA
Feb 24, 2025 07:30AM Gibraltar to Present at Gabelli Funds 35th Annual Pump, Valve, and Water Symposium
Feb 24, 2025 07:29AM Game-Changing Fuel Savings & Automation: DecarbX and S4E TECH Revolutionize Mining, Steel & Infrastructure Operations
Feb 24, 2025 07:25AM OS Therapies Forms Subsidiary OS Drug Conjugates and Initiates Review of Strategic Options for its tunable ADC & Drug Conjugates Platforms
Feb 24, 2025 07:11AM Edison Partners Exits RapidDeploy To Motorola Solutions
Feb 24, 2025 07:05AM FiscalNote Engages Palantir’s Former Head of Federal Contracting John Lee to Support the Implementation of the Company’s Market-Leading AI & Tech Solutions to Accelerate Government Efficiencie
Feb 24, 2025 07:05AM NeoGenomics to Participate in Upcoming Investor Conferences
Feb 24, 2025 07:01AM FiscalNote Announces Definitive Agreement to Divest Additional Non-Core Assets to Fuel Policy-Focused Growth, Boost Profitability, and Strengthen Balance Sheet
Feb 24, 2025 07:01AM Precision BioSciences Announces Oral Presentation at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
Feb 24, 2025 07:00AM Glaukos Announces FDA Acceptance of NDA Submission for Epioxa™
Feb 24, 2025 07:00AM Americas Gold & Silver Provides Galena Complex Operational and Exploration Update
Feb 24, 2025 07:00AM Healx Announces First Patient Dosed in Phase 2 Trial Evaluating HLX-1502 for the Treatment of Neurofibromatosis Type 1
Feb 24, 2025 07:00AM Synnovation Therapeutics Announces Second Program to Enter the Clinic: First Patient Dosed in Phase I Trial with SNV4818, a Potential Best-In-Class Pan-Mutant-Selective PI3Kα Inhibitor for the Treatm
Feb 24, 2025 07:00AM Laser Photonics Secures Second Navy Order Through Incredible Supply & Logistics for Advanced Laser Cleaning System
Feb 24, 2025 07:00AM Scale Biosciences Launches Five Single Cell Profiling Products, Unlocking Single Cell RNA Studies at Any Scale
Feb 24, 2025 07:00AM Halda Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial Evaluating HLD-0915 in Metastatic Castration-Resistant Prostate Cancer
Feb 24, 2025 07:00AM “It Was Like Something Out of a Wild West Movie”: 4Patriots Offers $10,000 Reward to Find “Power Thieves” Who Stole 112 of Its Latest-model Solar Generators in Brazen Train Robbery Outside Atl
Feb 24, 2025 07:00AM Iron Mountain to Present at Financial Conference
Feb 24, 2025 07:00AM Transportation at a Crossroads: Breakthrough Research Reveals How Shippers Are Balancing Sustainability With Cost Efficiency
Feb 24, 2025 07:00AM AN2 Provides Strategic Update for Phase 3 EBO-301 Trial in Treatment Refractory MAC Lung Disease
Feb 24, 2025 07:00AM PepGen Announces Positive Initial Results, Including Robust Splicing Correction, from Ongoing FREEDOM-DM1 Trial in Patients with DM1
Feb 24, 2025 07:00AM QuidelOrtho to Participate in the 46th Annual Raymond James Institutional Investor Conference
Feb 24, 2025 07:00AM Unity Announces Proposed $500.0 Million Offering of Convertible Senior Notes
Feb 24, 2025 07:00AM NMG to Present at BMO’s Global Metals, Mining and Critical Minerals Conference
Feb 24, 2025 07:00AM Bruker Advances Single-Cell Proteomics and Immunopeptidomics Performance; Unveils New Proteomics Software and Applications for Enhanced Biological Insights at US HUPO
Feb 24, 2025 07:00AM Aeva Announces Date for Fourth Quarter and Full Year 2024 Results and Conference Call
Feb 24, 2025 07:00AM Volato Begins Bitcoin Mining, Targets Citation CJ Series for First Aviation-Based Crypto Mining Platform
Feb 24, 2025 07:00AM Over 2,000 School Support Workers Join Strike Today
Feb 24, 2025 07:00AM United Therapeutics Corporation to Present at the TD Cowen 45th Annual Health Care Conference
Feb 24, 2025 07:00AM KalVista Pharmaceuticals to Present at Upcoming Investor Conferences
Feb 24, 2025 07:00AM Newly Formed Stronvar Aerospace Announces Acquisition of Electro Methods Inc., Investment from Blackstone
Feb 24, 2025 07:00AM OXIO Appoints Robb Robinson as SVP of Sales and Channels to Fuel Expansion Across the U.S.
Feb 24, 2025 07:00AM BirdseyePost Unveils Penny©, a Fully Autonomous AI Agent for Scalable, Data-Driven Marketing Across Print and Digital
Feb 24, 2025 07:00AM Latus Bio Announces Data Presentations in Support of its Preclinical Huntington’s Disease Gene Therapy Program
Feb 24, 2025 06:59AM U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Supplemental Biologics License Application for Opdivo® Plus Yervoy® for Patients with Unresectable or Metastatic Microsatellite Ins
Feb 24, 2025 06:50AM Wallbox Announces $10 Million Investment
Feb 24, 2025 06:50AM UnitedHealth Group Board Authorizes Payment of Quarterly Dividend
Feb 24, 2025 06:45AM Merck to Participate in the TD Cowen 45th Annual Health Care Conference
Feb 24, 2025 06:34AM DUBAI GAMES 2025: Montreal and Colorado Clinch the Battle of the Cities Crown
Feb 24, 2025 06:30AM Westlake Corporation Reports Fourth Quarter and Full Year 2024 Results
Feb 24, 2025 06:30AM Westlake Chemical Partners LP Announces Fourth Quarter and Full Year 2024 Results
Feb 24, 2025 06:30AM MAC Copper Limited Announces 2024 Resource and Reserve Statement and Production Guidance
Feb 24, 2025 06:30AM Zura Bio to Present at the Leerink Partners Global Healthcare Conference
Feb 24, 2025 06:24AM Piraeus FY 2024 Earnings & Business Plan 2025-2028
Feb 24, 2025 06:15AM Fresh Del Monte Produce Inc. Reports Fourth Quarter and Full Fiscal Year 2024 Financial Results
Feb 24, 2025 06:05AM Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Twelve Months Ended December 31, 2024
Feb 24, 2025 06:01AM Equitable Holdings Announces Cash Tender Offer for Up to 46,000,000 Units of AllianceBernstein Holding
Feb 24, 2025 06:00AM Owens Corning Delivers Full-Year Net Sales of $11.0 Billion; Generates Earnings of $647 Million and Adjusted EBIT of $2.0 Billion
Feb 24, 2025 06:00AM Revelation Biosciences, Inc. Receives Continued NASDAQ Listing Approval
Feb 24, 2025 06:00AM Summit Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Ivonescimab in Combination with Pfizer Antibody Drug Conjugates (ADCs)
View Newer Stories View Older Stories